Matthew Hall

68PUBLICATIONS
274CO-AUTHORS
Predictive and prognostic markersMolecular targetsGlycoconjugatesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Jul 10, 2026
Expanded Tox21 Biological Assay Panel for the Prediction of Drug-Induced Liver Injury and Cardiotoxicity.

|Apr 13, 2026
Author Correction: O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancer.

Yi Zhang, Shuyan Zhou, Yan Kai

|Feb 17, 2026
Integrating qHTS and QSAR Models to Identify Safe GPCR-Targeted Compounds: A Focus on hERG-Dependent Cardiotoxicity.

Xi Luo, Jinghua Zhao, Srilatha Sakamuru

|Sep 16, 2025
SAR Studies around the SULT1A1-Activated Alkylator YC-1 as Cytotoxic Agents against Biliary Tract Cancer Cells.

Ke Kong, Wei Zhao, Jonathan H Shrimp

|Jul 29, 2025
Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor.

Katarina Elez, Tim Hempel, Jonathan H Shrimp

|Jul 23, 2025
NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity.

Janna Heide, Agnes J Bilecz, Samarjit Patnaik

Pageof 12

Frequent Collaborators

11 joint publications

Samarjit Patnaik

11 joint publications

Min Shen

7 joint publications

Mark J Henderson

6 joint publications

Jacob S Roth